GLP-1 Side-Effect Triage · Last verified July 16, 2026

GLP-1 Heart Palpitations: When to Get Help and What to Do Next

By the Weight Loss Provider Guide Editorial Team · an independent comparison resource for GLP-1 telehealth providers. Published July 16, 2026 · Last verified: July 16, 2026

Heart palpitations while you’re on a GLP-1 are real, and they scare a lot of people. Across the eight medication labels we checked for this page, the FDA’s own trial data show a small average rise in resting heart rate — roughly 1 to 5 beats per minute, depending on the drug. But a racing, pounding, fluttering, or skipped-beat feeling doesn’t tell you what caused it. The same feeling can come from dehydration, low blood sugar (when a GLP-1 is paired with insulin or a sulfonylurea), caffeine, a cold medicine, thyroid problems, anemia, or a heart-rhythm issue that your GLP-1 didn’t create.

Here’s what this page does: show you which symptoms need emergency care, tell you what each current FDA label actually reports for eight GLP-1 medications, and help you give your clinician the exact information they need. That’s the whole job. Below, we’ll show you how to tell the difference, what each drug’s label actually says, and how to hand your doctor the right information in a short, guided check — so you get a real answer from the right person, fast.

What’s happening? → What to do

What should you do right now?

Check for red flags before you check the label

The right first move depends on your symptoms, not on which brand is on the box. If you have chest pain or pressure, you faint or nearly faint, you feel dizzy or lightheaded, or you can’t catch your breath, stop reading and call 911. Everything else on this page can wait. Your heart can’t.

What to do when you can’t reach your prescriber

• ●Emergency symptoms → 911.
• ●Ongoing or worsening symptoms that aren’t a clear emergency → urgent care or an ER for an in-person look.
• ●New but stable symptoms → message your provider portal, call the office, and ask specifically: what should I do before my next dose?
• ●Don’t sit on active or worsening symptoms for days waiting on an asynchronous telehealth reply. If it’s getting worse, it’s an in-person question.

What not to do

• Don’t take an extra GLP-1 dose.
• Don’t re-inject because you’re not sure the first shot “worked.”
• Don’t borrow someone’s beta blocker or heart-rhythm medication.
• Don’t assume water or electrolytes rule out a heart problem.
• Don’t treat a Reddit reply as medical clearance.
• Don’t stare at your watch and treat every little jump as a diagnosis. Checking your pulse once is smart. Repeated checking can feed anxiety and nudge your heart rate up, starting a feedback loop.

Can GLP-1 medications cause heart palpitations?

Two things are true at the same time. One: GLP-1 medications do nudge heart rate up a little. The leading explanations are a small direct effect on the heart’s natural pacemaker (the sinoatrial node) and a bump in the “gas pedal” side of your nervous system. Two: a palpitation you feel is not the same thing as a fast rate a machine measures, and neither one is the same as an abnormal rhythm a doctor diagnoses.

Palpitation, tachycardia, arrhythmia — what’s the difference?

Here’s why that matters: you can feel strong palpitations while your rhythm is completely normal. And, less comfortably, some rhythm problems cause almost no symptoms. That’s exactly why the feeling alone can’t sort this out — and why a check by someone with an ECG is worth it when something is new or keeps happening.

You might read on one page that palpitations aren’t among the most common GLP-1 side effects, and on another that the label tells you to report a racing heart. Both can be accurate: palpitations may not appear in the most common reactions list, but a rise in heart rate is still documented in the trials, and two of the eight labels tell patients to report racing or pounding at rest. That’s not a contradiction — it’s the honest complexity.

What the FDA labels say about heart rate: 8 GLP-1 medications compared

Last checked: July 16, 2026 · Source: current U.S. prescribing information via DailyMed

Label sources via DailyMed: Wegovy · Ozempic · Ozempic tablets / Rybelsus · Zepbound · Mounjaro · Trulicity · Saxenda · Foundayo (linked in table above)

Four rules for reading this table without scaring yourself

1. An average is not your ceiling. “1–4 bpm on average” is a group number. Some people barely move; a smaller share move more.
2. A palpitation is not tachycardia. Feeling it ≠ a measured fast rate ≠ an abnormal rhythm.
3. “No instruction found” is not “no risk.” It means we didn’t see a specific instruction there.
4. You can’t declare a winner from these numbers. Different trials, not a head-to-head race.

Are GLP-1 heart palpitations dangerous?

The reassuring fact: In the SELECT trial, once-weekly semaglutide 2.4 mg (the Wegovy dose) lowered major cardiovascular events — heart attack, stroke, or heart-related death — from 8.0% on placebo to 6.5% in 17,604 adults who had established heart disease plus overweight or obesity but not diabetes. That’s a 20% relative reduction (hazard ratio 0.80). It’s why Wegovy carries an approved heart-risk-reduction use for that group.

The honest catch: SELECT tested one drug, at one dose, in one defined group. It doesn’t prove that every GLP-1 product prevents heart events in every kind of person — and it definitely doesn’t tell you whether the flutter in your chest tonight is harmless. A medicine can be good for hearts overall and your new, at-rest palpitation can still deserve a look. Both are true.

Where extra care matters: if you have heart failure or a known rhythm disorder, loop in the clinician who manages that condition and the one who prescribed your GLP-1. A lasting change in resting heart rate is a conversation to have with your prescriber — not a reason to stop on your own.

When are GLP-1 heart palpitations an emergency?

A short episode that stops on its own may be less immediately concerning when there are no red flags — but duration alone can’t establish that it was harmless. A first-time or repeating episode still deserves to be written down and, when it fits the amber list above, reviewed.

Why we won’t give you a single “dangerous heart rate” number: Because one number can’t carry the whole story. A resting reading of 105 on your watch and a truly irregular rhythm with faintness are not the same situation — even if a monitor showed the same digits. The meaning depends on your baseline, whether the rhythm is regular, whether you’re moving, whether you have a fever, whether you’re dehydrated, and what other symptoms are riding along.

Why might your heart race after starting or increasing a GLP-1?

Dehydration and fluid loss

Nausea, vomiting, or diarrhea on a GLP-1 → you drink less → your blood volume drops → your heart beats faster to keep up. You might also feel dizzy when you stand. The Wegovy label links some low-blood-pressure and fainting events to fluid loss from stomach side effects, especially while the dose is going up. For the how and when of fluids and electrolytes, see our GLP-1 hydration and electrolyte guide — just don’t treat a sports drink as a diagnosis.

Low blood sugar in certain combinations

For most people, a GLP-1 on its own isn’t a big low-blood-sugar risk. The picture changes when a GLP-1 is combined with insulin or a sulfonylurea (older diabetes pills like glipizide or glimepiride that push your body to make more insulin). That combination can drop blood sugar, and low blood sugar can feel like a pounding, racing heart. The current labels flag this combination directly.

Caffeine, nicotine, alcohol, stimulants, and cold medicine

Plenty of everyday things speed up your heart. Before you blame the shot, take an honest inventory of the last day:

• Coffee and energy drinks
• Nicotine or vaping
• Alcohol
• ADHD or other stimulant medication
• Inhalers
• Decongestants like pseudoephedrine or phenylephrine
• Pre-workout powders

Thyroid trouble and anemia

An overactive thyroid or anemia can both cause a fast or pounding heartbeat, and you might not know you have either until a simple blood test finds it. Worth ruling out — but don’t decide it’s your thyroid just because someone online said it was theirs.

POTS, AFib, and other conditions

Sometimes the timing is a coincidence. Starting a GLP-1 can line up with a previously unrecognized rhythm condition rather than prove the medication created it. If you have a known rhythm disorder such as atrial fibrillation, or an autonomic condition such as POTS (postural orthostatic tachycardia syndrome), your bar for calling your clinician should be lower, not higher.

Anxiety is real — and not a reason to dismiss you

Anxiety genuinely amplifies how much you notice your heartbeat, and it can build a feedback loop. But “it’s probably just anxiety” is a conclusion to reach after new or worrying physical symptoms have been looked at — not a reason to wave you off before. You’re allowed to be anxious and deserving of a proper check.

Are palpitations more likely after a dose increase?

Think of your GLP-1 journey in three phases, and track them separately:

• 1.Starting out — your body’s first exposure.
• 2.Escalating — stepping up to a higher dose. Stomach side effects may become more prominent, increasing the risk of eating and drinking less.
• 3.Maintenance — settled at a steady dose.

When you log an episode, note your first dose date, your most recent dose-change date, the episode date, and whether you had any episodes at lower doses. That pattern is genuinely useful to a clinician. One thing we won’t do: give you a generic “increase every 7–14 days” or “just drop back a dose” rule. Dose decisions belong with your prescriber.

Do GLP-1 drugs cause AFib?

A faster heart rate is not AFib

A slightly quicker but regular pulse (sinus tachycardia) is a very different thing from atrial fibrillation, where the rhythm itself is irregular and disorganized. GLP-1s are associated with a small bump in rate. That’s not the same as causing an irregular rhythm.

Your watch is a witness, not a judge

Save any alert or tracing and bring it in — it’s genuinely useful to your clinician. Just don’t treat it as the final word, or as clearance to take your next dose.

If you already have AFib, POTS, or heart disease

This does not automatically mean GLP-1 treatment is off the table. It means the smart move is to talk to the clinician who manages your heart condition and the one who prescribed the GLP-1, and let them coordinate. A medicine can improve heart outcomes across a studied population and still need you evaluated when you develop a new rhythm symptom.

How long do GLP-1 heart palpitations last?

Other pages promise palpitations “usually settle in two to four weeks.” We’re not going to repeat that as a safety rule, because the labels don’t establish one class-wide duration for the feeling of palpitations, and “wait a month” is dangerous advice if the cause is a rhythm problem or ongoing dehydration.

What actually helps is writing down the details:

• When it started (exact or best guess)
• Whether it lasted seconds, minutes, or hours
• Whether it was constant or came and went
• Whether it stopped when you rested
• Whether it came back
• Whether it happened at rest or during activity
• Any dizziness, trouble breathing, or chest discomfort

And here’s the part people skip: even an episode that resolved still counts. It going away doesn’t remove the need to note it or the importance of telling your clinician if it repeats. Patterns are what get problems diagnosed.

Should you stop your GLP-1 if your heart is racing?

The one question to ask your prescriber is:

“Given this episode, should my next dose be continued, delayed, lowered, or held while I get evaluated?”

Here’s the range of things a prescriber might weigh with you:

• Staying at the current dose a bit longer
• Slowing down the dose increases
• Dropping to a dose you tolerated before
• Pausing treatment for a stretch
• Fixing a trigger like dehydration first
• Reviewing your other medications for interactions
• Switching to a different product
• Sending you to cardiology
• Stopping the GLP-1 if that’s the right call

And one thing we’ll say plainly: “just push through it so you don’t lose your progress” is not acceptable guidance. Your desire to keep losing weight doesn’t outrank a new heart symptom. An evaluation clarifies whether treatment can continue, needs adjusting, should pause, or should stop. You get a real answer instead of a guess.

What will a clinician check for?

Your history

They’ll want your drug and formulation, your dose, when you started, when you last increased, when you took your last dose, whether the episode was at rest or during activity, how long it lasted, whether it’s happened before, and everything else you take — prescription or not.

Vital signs — sometimes lying, sitting, and standing

If dehydration or a POTS-type pattern is on the table, a clinician may check your heart rate and blood pressure in different positions to see how they change when you stand.

ECG (also called an EKG)

This is the most common test for diagnosing a rhythm problem. An ECG can diagnose AFib or another arrhythmia when it captures that rhythm during the test. A normal office ECG is reassuring, but it doesn’t rule out an intermittent episode that simply isn’t happening in that two-minute window.

Lab tests

Depending on your story, they might check electrolytes, kidney function, glucose, a complete blood count (for anemia), and thyroid function. A normal panel doesn’t rule out a rhythm issue.

Holter or event monitor

Here’s a common frustration: your heart behaves perfectly during the office ECG, and the episode only hits at home. That’s exactly what a Holter monitor (a wearable that records your rhythm for a day or more) or a longer event monitor is for — it improves the chance of catching the rhythm during your normal life, though no monitor can guarantee it records every episode.

When cardiology enters the picture

A clinician may bring in a heart specialist if a rhythm problem is documented, if you keep having unexplained episodes, if you’ve fainted, if you have significant heart history, if symptoms persist despite adjustments, or if a test looks abnormal.

What if you use a compounded GLP-1?

The label table above tells you what the approved products’ labels report. It cannot tell you, for a compounded vial, what’s actually in it, whether the concentration is exactly right, whether it’s sterile and stable, or whether the dose you drew matched the prescription. Don’t read the branded numbers as a promise about a compounded product.

There’s also a 2026 wrinkle worth knowing: the FDA says semaglutide sodium and semaglutide acetate are different active ingredients from the semaglutide base used in approved products. The FDA doesn’t have information showing those salt forms behave the same way, and it isn’t aware of a lawful basis for using them in compounding. If you’re using a compounded semaglutide, it’s worth asking your pharmacy exactly what form it is.

What to write down if you’re worried about a dosing error

Dosing errors are a real, documented issue with compounded injectables — usually tied to confusion between milligrams (mg), milliliters (mL), and syringe units. If a concerning symptom followed a dose, gather:

• Concentration in mg/mL
• Your prescribed dose in mg
• The directions in mL or units
• Your syringe size
• How many units you actually drew
• A photo of the vial
• The pharmacy name, lot number, and beyond-use date
• The time you took it

As of May 31, 2026, the FDA reported roughly 990 adverse-event reports linked to compounded semaglutide and more than 730 linked to compounded tirzepatide. Those raw counts can’t be turned into a rate, causation isn’t always established, and underreporting is likely. They’re a signal to take dosing seriously — not a statistic to compare safety with.

What information should you send your prescriber?

The difference between a vague message and a good one is the difference between a back-and-forth and a clear plan. Here’s a template you can adapt (use the checker above to generate and copy it):

“I take [medication / form] at [dose]. My last dose was [date/time], and my most recent dose change was [date]. At [time], while [resting / active], I felt [racing / pounding / fluttering / skipped beats] for about [duration]. My measured pulse was [number / not measured], and [device] showed [result]. I did / did not have chest pain, shortness of breath, dizziness, near-fainting, or fainting. I’ve had [vomiting / diarrhea / reduced intake], and I also take [relevant medications]. Should I be evaluated before my next dose, and should that dose be continued, delayed, adjusted, or held?”

7-day GLP-1 palpitation log

Print this table or screenshot it to track episodes. Patterns are what get problems diagnosed.

Use your browser’s print function (Ctrl+P / Cmd+P) to print this log, or screenshot this section.

Can you switch to another GLP-1 after palpitations?

Before you go shopping for a different medication, get these answered first:

• Was an actual rhythm problem found?
• Were you significantly dehydrated?
• Was your blood sugar low?
• Was the dose measured correctly?
• Did another medication contribute?
• Does the symptom repeat with treatment?
• Do you have a heart, thyroid, or iron issue that needs treating on its own?

Why we’re not dropping a provider comparison here: because if you’re mid-symptom, what you need isn’t a cheaper or flashier telehealth program. You need continuity of your clinical information and a real answer about your heart. A “best providers” table would be serving our interest, not yours — and this page isn’t the place for it.

Once your symptoms have been evaluated, and you and your clinician decide GLP-1 treatment is still right for you, the next question becomes which program fits your needs. When you’re at that point, the quiz at the bottom of this page can help.

Frequently asked questions about GLP-1 heart palpitations

How did we research and verify this guide?

Our source order: current FDA labels first, then FDA safety communications, then patient guidance from the AHA, NIH, and MedlinePlus, then systematic reviews and randomized-trial results, then reputable clinical references. Patient forums were used only to understand how people describe the experience — never as medical evidence.

The rules we held ourselves to: no cross-trial safety rankings, no diagnosis from a description, no “the drug caused it” from timing alone, no incidence math from raw adverse-event reports, no claim that a compounded product is equivalent to a brand product, no universal dose-hold instruction, and no provider sales pitch inside the safety sections.

Found an error? If a label changed, a link broke, or we got a number wrong, tell us — our corrections page is there for exactly that.

The bottom line

If you’re feeling chest pain or pressure, fainting or near-fainting, dizziness, or severe shortness of breath right now — stop reading and call 911. That’s the one instruction on this page that overrides everything else.

For everyone else: a small heart-rate rise is a documented GLP-1 effect, and these medications have generally looked favorable on heart outcomes in large studies. But your palpitation deserves the right next step — self-monitoring, a prescriber call, or emergency care — based on your symptoms, not a guess. Use the checker above, take the note to your doctor, and let the right person give you a real answer.

This guide is general information, not medical advice, and it can’t diagnose the cause of your symptoms. Always talk with the clinician who manages your medication, and call 911 for emergency symptoms. See our medical disclaimer.